Papers
3
Total Citations
141
H-Index
3
About
No biography available yet.
Research Focus
Neoadjuvant therapy3 · 141 citations
Cancer3 · 141 citations
Surgery3 · 141 citations
Nivolumab3 · 141 citations
Immunotherapy3 · 141 citations
Internal medicine3 · 141 citations
Ipilimumab3 · 141 citations
Lung cancer3 · 141 citations
Medicine3 · 141 citations
Breast cancer2 · 122 citations
Oncology2 · 122 citations
Perioperative2 · 122 citations
Key Achievements
3
H-Index
3
Papers
141
Total Citations
47
Avg Citations/Paper
🏆 Most Cited Paper
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer
94 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 40
🏛 Institutions: The University of Texas MD Anderson Cancer Center
Top Papers
- 1
- 2
- 3
Key Collaborators
JVJohn V. Heymach3 shared papersWNWilliam N. William3 shared papersDLDon L. Gibbons3 shared papersTCTina Cascone3 shared papersDCDavid C. Rice3 shared papersSGStephen G. Swisher3 shared papersAAAra A. Vaporciyan3 shared papersWLWayne L. Hofstetter3 shared papersMBMara B. Antonoff3 shared papersRJReza J. Mehran3 shared papersBSBoris Sepesi3 shared papersJAJack A. Roth3 shared papersAWAnnikka Weissferdt2 shared papersAPApar Pataer2 shared papersRRRavi Rajaram2 shared papersCHCheuk Hong Leung2 shared papersGLGarrett L. Walsh2 shared papersASAnne S. Tsao2 shared papersFVFrank V. Fossella1 shared papersAWA. Weissferdt1 shared papers
Not generated yet